These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 1771591)

  • 41. [Perinatal effects of general anesthesia in pregnancy].
    Rondinelli M; Tambuscio B; Suma V; Donato A; de Laurentiis G
    Riv Ital Ginecol; 1977; 58(1-2):29-44. PubMed ID: 617872
    [No Abstract]   [Full Text] [Related]  

  • 42. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review.
    Bullo M; Tschumi S; Bucher BS; Bianchetti MG; Simonetti GD
    Hypertension; 2012 Aug; 60(2):444-50. PubMed ID: 22753220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adverse effects of cardiovascular drug therapy on the fetus and neonate.
    Witter FR; King TM; Blake DA
    Obstet Gynecol; 1981 Nov; 58(5 Suppl):100S-5S. PubMed ID: 7031536
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Warfarin embryopathy].
    Galil A; Biale Y; Bar-Ziv J
    Harefuah; 1984 Dec; 107(12):390-2. PubMed ID: 6532923
    [No Abstract]   [Full Text] [Related]  

  • 45. [Fetopathy associated with exposure to angiotensin converting enzyme inhibitors].
    Neves S; Santos R; Gomes C; Correia AJ
    Acta Med Port; 2010; 23(4):697-700. PubMed ID: 20687999
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fetotoxic risk of AT1 blockers exceeds that of angiotensin-converting enzyme inhibitors: an observational study.
    Weber-Schoendorfer C; Kayser A; Tissen-Diabaté T; Winterfeld U; Eleftheriou G; Te Winkel B; Diav-Citrin O; Greenall A; Hoeltzenbein M; Schaefer C
    J Hypertens; 2020 Jan; 38(1):133-141. PubMed ID: 31568057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A 14-year-old girl with renal abnormalities after brief intrauterine exposure to enalapril during late gestation.
    Guron G; Mölne J; Swerkersson S; Friberg P; Hansson S
    Nephrol Dial Transplant; 2006 Feb; 21(2):522-5. PubMed ID: 16311256
    [No Abstract]   [Full Text] [Related]  

  • 48. [Kidney insufficiency and persistent hypotension following compromise of the renin-angiotensin system in a fetus and a young infant].
    van Lieburg AF; Monnens LA
    Ned Tijdschr Geneeskd; 2001 Apr; 145(14):695-8. PubMed ID: 11530709
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ACE inhibitors and congenital anomalies.
    Friedman JM
    N Engl J Med; 2006 Jun; 354(23):2498-500. PubMed ID: 16760451
    [No Abstract]   [Full Text] [Related]  

  • 50. Neonatal acute renal failure secondary to maternal exposure to telmisartan, angiotensin II receptor antagonist.
    Pietrement C; Malot L; Santerne B; Roussel B; Motte J; Morville P
    J Perinatol; 2003; 23(3):254-5. PubMed ID: 12732865
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The use of angiotensin converting enzyme (ACE) inhibitors during pregnancy clearly increases the risk of congenital malformations].
    de Jong-van den Berg LT; Bakker MK; de Walle HE; van den Berg PB
    Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2222-3. PubMed ID: 17061436
    [No Abstract]   [Full Text] [Related]  

  • 52. Pregnancy outcome with ACE-inhibitor use in early pregnancy.
    Steffensen FH; Nielsen GL; Sørensen HT; Olesen C; Olsen J
    Lancet; 1998 Feb; 351(9102):596. PubMed ID: 9492804
    [No Abstract]   [Full Text] [Related]  

  • 53. Renal tubular dysgenesis with hypoplastic calvaria: report of two cases.
    Erdogan S; Kacar A; Yilmazer D; Satar M; Tunali N
    Genet Couns; 2004; 15(3):335-9. PubMed ID: 15517826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Fetal hydantoin syndrome].
    Gómez Gómez M; Cruz Bolaños JA
    Bol Med Hosp Infant Mex; 1981; 38(2):291-9. PubMed ID: 7259848
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fetal toxic effects of angiotensin II receptor antagonists: case report and follow-up after birth.
    Bos-Thompson MA; Hillaire-Buys D; Muller F; Dechaud H; Mazurier E; Boulot P; Morin D
    Ann Pharmacother; 2005 Jan; 39(1):157-61. PubMed ID: 15590878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Foetal kidney maldevelopment in maternal use of angiotensin II type I receptor antagonists.
    Daïkha-Dahmane F; Levy-Beff E; Jugie M; Lenclen R
    Pediatr Nephrol; 2006 May; 21(5):729-32. PubMed ID: 16565869
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renin Angiotensin System Blocker Fetopathy: A Midwest Pediatric Nephrology Consortium Report.
    Nadeem S; Hashmat S; Defreitas MJ; Westreich KD; Shatat IF; Selewski DT; Onder AM; Chiang M; Weaver DJ; Steinke J; Barcia J; Hernandez J; Hidalgo G; Ingraham SE; Abitbol CL; Pan C; Greenbaum LA
    J Pediatr; 2015 Oct; 167(4):881-5. PubMed ID: 26130112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adverse reactions to drugs: angiotensin-converting enzyme inhibitors and pregnancy.
    Birbari AE
    J Med Liban; 1993; 41(2):99. PubMed ID: 8057352
    [No Abstract]   [Full Text] [Related]  

  • 59. [Alcoholic embryopathy].
    Holtorff J; Hinkel GK
    Z Gesamte Inn Med; 1981 Aug; 36(16):587-93. PubMed ID: 7027654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Are ACE inhibitors safe in pregnancy?
    Smith AM
    Lancet; 1989 Sep; 2(8665):750-1. PubMed ID: 2571004
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.